Zum Hauptinhalt springenSkip to page footer

Publikationen

Ausgewählte Publikationen

  • Steininger P, Korn K, Knöll A, Überla K. (2025) Neu in der Virologie. Bayerisches Ärzteblatt. 03: 64-70.
  • Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, Manger K, Manger B, Korn K, Kleyer A, Simon D, Harrer T, Schett G, Fagni F. (2024) Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. Rheumatology (Oxford). 63(5): 1377-1383.
  • Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, Mueller-Schmucker SM, Beileke S, Goekkaya M, Kling E, Geldmacher C, Rubio-Acero R, Plank M, Christa C, Willmann A, Vu M, Einhauser S, Weps M, Lampl BMJ, Almanzar G, Kousha K, Schwägerl V, Liebl B, Weber B, Drescher J, Scheidt J, Gefeller O, Messmann H, Protzer U, Liese J, Hoelscher M, Wagner R, Überla K, Steininger P, CoVaKo Study Group. (2024) Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults. J Clin Virol. 170: 105622.
  • Kießling M, Cole JJ, Kübel S, Klein P, Korn K, Henry AR, Laboune F, Fourati S, Harrer E, Harrer T, Douek DC, Überla K, Nganou-Makamdop K. (2024) Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection. Nat Commun. 15(1): 10200.
  • Byren HC, Holzer A, Müller A, Korn K, Backovic M, Harrer EG, Bergmann S, Harrer T, Neipel F. (2024) Increased human herpesvirus-8 neutralizing response during remission from Kaposi's sarcoma. J Gen Virol. 105(11).
  • Stuebs FA, Behrens AS, Seibold A, Adler W, Geppert C, Hartmann A, Knöll A, Koch MC, Mehlhorn G, Beckmann MW, Theuser AK, Schulmeyer CE, Gass P, Dietl AK. (2024) Impact of the Corona Pandemic on Cervical Cancer Screening Assessment. In Vivo. 38(2): 734-740.
  • Behrens AS, Dietl AK, Adler W, Geppert C, Hartmann A, Knöll A, Beckmann MW, Mehlhorn G, Koch MC, E Schulmeyer C, Seibold A, Gass P, Stuebs FA. (2024) Evaluation of endocervical curettage (ECC) in colposcopy for detecting cervical intraepithelial lesions. Arch Gynecol Obstet. 310(6): 3037-3045.
  • Gerstenberg J, Klinker H, Baier M, von Braun A, Seybold U, Helbig C, Däumer M, Korn K, Stephan C, Schleenvoigt BT. (2024) Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance. Open Forum Infect Dis. 11(9): ofae480.
  • Kocher K, Moosmann C, Drost F, Schülein C, Irrgang P, Steininger P, Zhong J, Träger J, Spriewald B, Bock C, Busch DH, Bogdan C, Schubert B, Winkler TH, Tenbusch M, Schuster EM, Schober K. (2024) Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual. Lancet Infect Dis. 24(5): e272-e274.
  • Einhauser S, Asam C, Weps M, Senninger A, Peterhoff D, Bauernfeind S, Asbach B, Carnell GW, Heeney JL, Wytopil M, Fuchs A, Messmann H, Prelog M, Liese J, Jeske SD, Protzer U, Hoelscher M, Geldmacher C, Überla K, Steininger P, Wagner R, CoVaKo Study group. (2024) Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses. EBioMedicine. 110: 105438.
  • Almanzar G, Koosha K, Vogt T, Stein A, Ziegler L, Asam C, Weps M, Schwägerl V, Richter L, Hepp N, Fuchs A, Wagenhäuser I, Reusch J, Krone M, Geldmacher C, Protzer U, Steininger P, Überla K, Wagner R, Liese J, Prelog M. (2024) Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2. J Med Virol. 96(6): e29739.
  • Ebinger A, Santos PD, Pfaff F, Dürrwald R, Kolodziejek J, Schlottau K, Ruf V, Liesche-Starnecker F, Ensser A, Korn K, Ulrich R, Fürstenau J, Matiasek K, Hansmann F, Seuberlich T, Nobach D, Müller M, Neubauer-Juric A, Suchowski M, Bauswein M, Niller HH, Schmidt B, Tappe D, Cadar D, Homeier-Bachmann T, Haring VC, Pörtner K, Frank C, Mundhenk L, Hoffmann B, Herms J, Baumgärtner W, Nowotny N, Schlegel J, Ulrich RG, Beer M, Rubbenstroth D. (2024) Lethal Borna disease virus 1 infections of humans and animals - in-depth molecular epidemiology and phylogeography. Nat Commun. 2024;15(1): 7908.
  • Obermeier M, Ehret R, Thielen A, Daeumer M, Jensen B, Elsner C, Daechert C, Knops E, Geringer E, Heger E, Wolf E, Wiesmann F, Walter H, Hauser A, Hoffmann C, Goerzer I, Verheyen J, Eberle J, Metzner K, Korn K, Lengauer T, Meixenberger K, Stuermer M, Muenchhoff M, Braun P, Esser S, Klimkait T, Kaiser R, Luebke N. (2024) HIV-GRADE drug-resistance interpretation web tool update for capsid and post-attachment inhibitors. J Int AIDS Soc. 27 Suppl 6: 146-146.
  • Stuebs FA, Mergel F, Koch MC, Dietl AK, Schulmeyer CE, Adler W, Geppert C, Hartman A, Knöll A, Beckmann MW, Gass P, Mehlhorn G. (2023) Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum. Arch Gynecol Obstet. 307(5): 1567-1572.
  • Koch T, Korn K, Lang , Zeun J, Graw F, Voelkl S, Thomas S, Mackensen A, Kremer A, Reimann H. (2023) Identification of CD4+T Cells targeting DM-sensitive Antigens in mismatched HLA-DP Alleles as Mediators for selective Graftversus-Leukemia Effect. Oncology Research and Treatment. 46 Suppl 5: 196-196.
  • Peterhoff D, Wiegrebe S, Einhauser S, Patt AJ, Beileke S, Günther F, Steininger P, Niller HH, Burkhardt R, Küchenhoff H, Gefeller O, Überla K, Heid IM, Wagner R. (2023) Population-based study of the durability of humoral immunity after SARS-CoV-2 infection. Front Immunol. 14: 1242536.
  • Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S, Warkentin L. (2023) Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study. BMC Med. 21(1): 358.
  • Cordsmeier A, Jungnickl D, Herrmann A, Korn K, Ensser A: (2023) Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System. Int J Mol Sci. 24(9): 8156.
  • Warkentin L, Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S. (2023) Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study. BMC Med. 21(1): 218.
  • El Kenz B, Schmidt KG, Ogungbemi-Alt VK, Bergmann S, Steininger P, Korn K, Spriewald B, Harrer EG, Nganou-Makamdop K, Harrer T. (2023) Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller. Viruses. 15(2): 567.
  • El Kenz B, Korn K, Steininger P, Schmidt KG, Nganou-Makamdop K, Harrer T. (2023) HIV-1-specific T-cells in an HIV-1-infected but HIV-1 antibody negative patient on long-term antiretroviral therapy. HIV Med. 24 Suppl 1: 65-66.
  • Klessing S, Peter AS, Fraedrich K, Wagner JT, Kummer M, Deutschmann J, Steininger P, Steibl HD, Überla K. (2023) Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions? Viruses. 15(2): 397.
  • Frey B, Schmitter C, Donaubauer AJ, Zuelch L, Korn K, Ueberla K, Schmidt M, Dorfler A, Engelhorn T, Eyuepoglu I, Putz F, Fietkau R, Semrau S, Gaipl U. (2023) Critical illness and early mortality of brain cancer patients due to reactivation of human cytomegalovirus (HCMV) during radiotherapy of the brain - updated results of the prospective GLIO-CMV01 trial Strahlenther Onkol. 199 Suppl 1: S33-S34.
  • Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, Wytopil M, Beileke S, Schäfer S, Zhong J, Ssebyatika G, Krey T, Falcone V, Schülein C, Peter AS, Nganou-Makamdop K, Hengel H, Held J, Bogdan C, Überla K, Schober K, Winkler TH, Tenbusch M. (2023) Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci Immunol. 8(79): eade2798.
  • Stuebs FA, Dietl AK, Koch MC, Adler W, Geppert CI, Hartmann A, Knöll A, Mehlhorn G, Beckmann MW, Schulmeyer CE, Heindl F, Emons J, Seibold A, Behrens AS, Gass P. (2023) Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study. Cancers (Basel). 15(18): 4633.
  • Steininger P, Herbst L, Bihlmaier K, Willam C, Körper S, Schrezenmeier H, Klüter H, Pfister F, Amann K, Weiss S, Krüger DH, Zimmermann R, Korn K, Hofmann J, Harrer T. (2023) Fatal Puumala Hantavirus Infection in a Patient with Common Variable Immunodeficiency (CVID). Microorganisms. 11(2): 283.
  • Schmidt KG, Harrer EG, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, Schett G, Knobloch CS, Nganou-Makamdop K, Harrer T. (2023) Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine. Infection. 51(6): 1657-1667.
  • Steininger P, Ensser A, Knöll A, Korn K. (2023) Results of Tick-Borne Encephalitis Virus (TBEV) Diagnostics in an Endemic Area in Southern Germany, 2007 to 2022. Viruses. 15(12): 2357.
  • Biljecki M, Eisenhut K, Beltrán E, Winklmeier S, Mader S, Thaller A, Eichhorn P, Steininger P, Flierl-Hecht A, Lewerenz J, Kümpfel T, Kerschensteiner M, Meinl E, Thaler FS. (2023) Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation. Neurol Neuroimmunol Neuroinflamm. 2023;10(3): e200090.
  • Steininger P, Korn K, Hackstein H, Strasser EF. (2023) Validation of a Parvovirus B19 NAT Assay for Screening of Umbilical Cord Blood for Allogenic Hematopoietic Stem Cell Donation. Transfus Med Hemother. 51(1): 48-51.
  • Bertram R, Grebenstein L, Gualdi S, Seibold B, Birkmann R, Korn K, Bisping J, Schabik R. (2022) Detection of asymptomatic SARS-CoV-2 infections in daycare centers, schools, and companies for regional pandemic containment by a PCR testing laboratory cooperative between July 2021 and June 2022. GMS Hyg Infect Control. 17: Doc22.
  • Einhauser S, Peterhoff D, Beileke S, Günther F, Niller HH, Steininger P, Knöll A, Korn K, Berr M, Schütz A, Wiegrebe S, Stark KJ, Gessner A, Burkhardt R, Kabesch M, Schedl H, Küchenhoff H, Pfahlberg AB, Heid IM, Gefeller O, Überla K, Wagner R. (2022) Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County-Results from a Population-Based Longitudinal Study in Germany. Viruses. 14(6): 1168.
  • Meier H, Bauer C, Finkenzeller W, Nentwich J, Städt M, Steininger P, Korn K, Ensser A, Erbguth F. (2022) Die Borna-Virus-Enzephalitis als Differenzialdiagnose zur seronegativen Autoimmunenzephalitis [Bornavirus encephalitis as a differential diagnosis to seronegative autoimmune encephalitis]. Nervenarzt. 93(8): 835-837. German.
  • Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, Huzly D, Agaimy A, Bryceson YT, Choo S, Chow CW, Dückers G, Fasth A, Fraitag S, Gräwe K, Haxelmans S, Holzinger D, Hudowenz O, Hübschen JM, Khurana C, Kienle K, Klifa R, Korn K, Kutzner H, Lämmermann T, Ledig S, Lipsker D, Meeths M, Naumann-Bartsch N, Rascon J, Schänzer A, Seidl M, Tesi B, Vauloup-Fellous C, Vollmer-Kary B, Warnatz K, Wehr C, Neven B, Vargas P, Sepulveda FE, Lehmberg K, Schmitt-Graeff A, Ehl S. (2022) Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. J Allergy Clin Immunol. 149(1): 388-399.
  • Kremer AE, Kremer AN, Willam C, Völkl S, Verhagen J, Achenbach S, van der Meijden ED, Lang V, Aigner M, Maier C, Tenbusch M, Korn K, Lutzny-Geier G, Spoerl S, Strauß R, Vetter M, Überla K, Neurath MF, Mackensen A, Schiffer M, Hackstein H. (2021) Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 51(10): 2478-2484.
  • Wollschläger P, Todt D, Gerlitz N, Pfaender S, Bollinger T, Sing A, Dangel A, Ackermann N, Korn K, Ensser A, Steinmann E, Buhl M, Steinmann J. (2021) SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay. Clin Microbiol Infect. 27(9): 1353.
  • Steininger PA, Seifert F, Balk S, Kuramatsu J, Kremer AE, Coras R, Engelhorn T, Maier C, Tenbusch M, Korn K, Ensser A. (2021) Pearls & Oy-sters: SARS-CoV-2 Infection of the CNS in a Patient With Meningeosis Carcinomatosa. Neurology. 96(10): 496-499.
  • Ziegler K, Steininger P, Ziegler R, Steinmann J, Korn K, Ensser A. (2020) SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene. Euro Surveill. 25(39): 2001650.
  • Nagel A, Knöll A. (2020) Virusinfektionen in der Gynäkologie - Aktuelle Entwicklungen bei humanen Papillomviren und Herpesviren. Gynäkologische Praxis. 46: 427-442.
  • Steininger P, Korn K, Knöll A. HTL V-Diagnostik bei neurologischen Erkrankungen – sinnvolle Anforderungen und korrekte Interpretation. NRZ Retroviren Bulletin. 02: 7-9.
  • Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R. (2020) Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy. Clin Cancer Res. 26(13): 3259-3270.
  • Nagel A, Dimitrakopoulou E, Teig N, Kern P, Lücke T, Michna D, Korn K, Steininger P, Shahada K, Neumann K, Überla K. (2020) Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay. PLoS One. 15(1): e0227143.
  • Elling R, Böttcher S, du Bois F, Müller A, Prifert C, Weissbrich B, Hofmann J, Korn K, Eis-Hübinger AM, Hufnagel M, Panning M. (2019) Epidemiology of Human Parechovirus Type 3 Upsurge in 2 Hospitals, Freiburg, Germany, 2018. Emerg Infect Dis. 25(7): 1384-1388.
  • Kohmer N, Nagel A, Berger A, Enders M, Hamprecht K, Korn K, Kortenbusch M, Überla K, Rabenau HF. (2019) Laboratory diagnosis of congenital CMV infection in newborns: Impact of pre-analytic factors. J Clin Virol. 115: 32-36.
  • Coras R, Korn K, Kuerten S, Huttner HB, Ensser A. (2019) Severe bornavirus- encephalitis presenting as Guillain-Barré-syndrome. Acta Neuropathol. 137(6): 1017-1019.
Öffnet Webseite der FAU - Friedrich Alexander Universität - Medizinische Fakultät Erlangen-Nürnberg
Öffnet PDF Zertifikat TÜV SÜD ISO 9001
Öffnet Webseite der Forschungsstiftung Medizin